AI assistant
Sending…
BIO KEY INTERNATIONAL INC — Director's Dealing 2022
Sep 15, 2022
35397_dirs_2022-09-15_69002299-3ce4-486c-a73e-08ce3029d255.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO KEY INTERNATIONAL INC (BKYI)
CIK: 0001019034
Period of Report: 2022-09-14
Reporting Person: DEPASQUALE MICHAEL W (Director, Chief Executive Officer, Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-14 | Common Stock | P | 1265 | $1.60 | Acquired | 70723 | Direct |
| 2022-09-14 | Common Stock | P | 4 | $1.57 | Acquired | 70727 | Direct |
Footnotes
F1: Holdings do not include options to purchase 39,584 shares.
More from BIO KEY INTERNATIONAL INC
Regulatory Filings
2026
May 18
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Director's Dealing
2026
Jan 5
Regulatory Filings
2025
Dec 2
Regulatory Filings
2025
Dec 2